Neoadjuvant chemotherapy (NAC) is widely used in early-stage and locally advanced HER2-negative breast cancer, yet pathological complete response (pCR) is achieved in only a subset of patients.
We comprehensively analyzed independent MI datasets from the Gene Expression Omnibus database. The relationships between MI and the differentially expressed genes were evaluated through differential ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results